These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21422053)

  • 1. Accumulated and differential effects of life events on cognitive decline in older persons: depending on depression, baseline cognition, or ApoE epsilon4 status?
    Comijs HC; van den Kommer TN; Minnaar RW; Penninx BW; Deeg DJ
    J Gerontol B Psychol Sci Soc Sci; 2011 Jul; 66 Suppl 1():i111-20. PubMed ID: 21422053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
    Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
    Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
    Knopman DS; Mosley TH; Catellier DJ; Coker LH;
    Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function in an elderly population: interaction between vitamin B12 status, depression, and apolipoprotein E ε4: the Hordaland Homocysteine Study.
    Vogiatzoglou A; Smith AD; Nurk E; Drevon CA; Ueland PM; Vollset SE; Nygaard HA; Engedal K; Tell GS; Refsum H
    Psychosom Med; 2013 Jan; 75(1):20-9. PubMed ID: 23213264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
    J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery.
    Silbert BS; Evered LA; Scott DA; Cowie TF
    Ann Thorac Surg; 2008 Sep; 86(3):841-7. PubMed ID: 18721571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E and cognitive performance: a meta-analysis.
    Small BJ; Rosnick CB; Fratiglioni L; Bäckman L
    Psychol Aging; 2004 Dec; 19(4):592-600. PubMed ID: 15584785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
    Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
    J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems meeting basic needs moderate the association between the APOE epsilon4 allele and cognitive decline.
    Sachs-Ericsson N; Corsentino E; Collins N; Sawyer K; Blazer DG
    Aging Ment Health; 2010 Mar; 14(2):138-44. PubMed ID: 19946803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
    Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease.
    Spalletta G; Bernardini S; Bellincampi L; Federici G; Trequattrini A; Ciappi F; Bria P; Caltagirone C; Bossù P
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):879-87. PubMed ID: 17911365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change in cognitive performance among individuals with mild cognitive impairment.
    Albert M; Blacker D; Moss MB; Tanzi R; McArdle JJ
    Neuropsychology; 2007 Mar; 21(2):158-69. PubMed ID: 17402816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ω-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression.
    Samieri C; Féart C; Proust-Lima C; Peuchant E; Dartigues JF; Amieva H; Barberger-Gateau P
    Neurobiol Aging; 2011 Dec; 32(12):2317.e13-22. PubMed ID: 20570406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between APOE status and neuropsychological memory test performance: an analysis of the Canadian Study of Health and Aging.
    Klages J; Fisk JD
    Brain Cogn; 2002 Jul; 49(2):201-4. PubMed ID: 15259389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between ApoE epsilon4 and cognitive impairment after stroke.
    Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.
    O'Hara R; Schröder CM; Kraemer HC; Kryla N; Cao C; Miller E; Schatzberg AF; Yesavage JA; Murphy GM
    Neurology; 2005 Aug; 65(4):642-4. PubMed ID: 16116137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistasis between APOE and nicotinic receptor gene CHRNA4 in age related cognitive function and decline.
    Reinvang I; Lundervold AJ; Wehling E; Rootwelt H; Espeseth T
    J Int Neuropsychol Soc; 2010 May; 16(3):424-32. PubMed ID: 20331911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE epsilon4 allele carriers: Biological, psychological, and social variables associated with cognitive impairment.
    Sachs-Ericsson NJ; Sawyer KA; Corsentino EA; Collins NA; Blazer DG
    Aging Ment Health; 2010 Aug; 14(6):679-91. PubMed ID: 20686979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.